tiprankstipranks
Trending News
More News >
Nuvation Bio (NUVB)
NYSE:NUVB
US Market

Nuvation Bio (NUVB) Income Statement

Compare
761 Followers

Nuvation Bio Income Statement

Last quarter (Q4 2025), Nuvation Bio's total revenue was $41.87M, an increase of 633.06% from the same quarter last year. In Q4, Nuvation Bio's net income was $-36.59M. See Nuvation Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 62.90M$ 7.87M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 54.46M$ 795.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 267.52M$ 593.42M$ 99.82M$ 119.73M$ 93.32M
Depreciation and Amortization
$ 0.00$ 683.00K$ 222.00K$ 199.00K$ 184.00K
EBITDA
$ -190.94M$ -566.91M$ -75.58M$ -119.53M$ -93.13M
Operating Income
$ -213.06M$ -592.63M$ -99.82M$ -119.73M$ -93.32M
Other Income/Expenses
$ 8.44M$ 24.69M$ 24.02M$ 15.54M$ 6.47M
Pretax Income
$ -204.63M$ -567.94M$ -75.80M$ -104.20M$ -86.85M
Net Income
$ -204.63M$ -567.94M$ -75.80M$ -104.20M$ -86.85M
Per Share Metrics
Basic EPS
$ -0.60$ -2.11$ -0.35$ -0.48$ -0.44
Diluted EPS
$ -0.60$ -2.11$ -0.35$ -0.48$ -0.44
Weighted Average Shares Outstanding
341.54M 268.77M 218.88M 216.72M 197.89M
Weighted Average Shares Outstanding (Diluted)
341.54M 268.77M 218.88M 216.72M 197.89M
Currency in USD

Nuvation Bio Earnings and Revenue History